Status:
COMPLETED
A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Healthy
Pneumococcal Infections
Eligibility:
All Genders
20-40 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adults.
Eligibility Criteria
Inclusion
- Males and females in good health, ages 20-40, with no history of pneumococcal vaccination
Exclusion
- Subjects with a recent febrile illness
- Known or suspected immune dysfunction, conditions associated with immunosuppression, and receipt of immunosuppressive chemotherapy, including long-term corticosteroid therapy
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00127153
Start Date
March 1 2005
End Date
May 1 2005
Last Update
January 29 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.